Evidence and Challenges for Translation and Population Impact of the Diabetes Prevention Program
Purpose of Review Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource–intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the ra...
Saved in:
| Published in | Current diabetes reports Vol. 20; no. 3; p. 9 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
New York
Springer US
01.03.2020
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1534-4827 1539-0829 1539-0829 |
| DOI | 10.1007/s11892-020-1293-4 |
Cover
| Abstract | Purpose of Review
Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource–intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement.
Recent Findings
For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve.
Summary
Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale. |
|---|---|
| AbstractList | Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement.PURPOSE OF REVIEWType 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement.For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale.RECENT FINDINGSFor more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale. Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement. For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale. Purpose of Review Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource–intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement. Recent Findings For more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve. Summary Efforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale. Purpose of ReviewType 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource–intensive lifestyle support interventions resulting in modest weight loss via healthy diet changes and physical activity can lower the rate of diabetes development by 58%. We performed a review of efforts to translate and implement DPP-like programs throughout the USA to identify challenges and opportunities for improvement.Recent FindingsFor more than a decade, multiple stakeholders have worked to translate evidence-based principles of diabetes prevention to reach 84 million Americans with prediabetes. DPP-like programs have been delivered by over 1500 organizations, reaching almost 300,000 people, but this number represents less than 1% of the target population. Research has uncovered large gaps in efforts to diagnose, raise awareness, and provide access to DPP-like programs for adults with prediabetes, requiring further stakeholder engagement and coordination to resolve.SummaryEfforts to address prevailing gaps in diabetes prevention must address distinct and sometimes conflicting priorities and concerns of stakeholders. Our review recommends several areas of further research and action to improve type 2 diabetes prevention on a population scale. |
| ArticleNumber | 9 |
| Author | O’Brien, Matthew J. Ackermann, Ronald T. |
| AuthorAffiliation | 3 Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine, 300 E Superior St #15-703, Chicago, IL 60611, USA 2 Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 6th Floor, Chicago, IL 60611, USA 1 Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL 60611, USA |
| AuthorAffiliation_xml | – name: 1 Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 10th Floor, Chicago, IL 60611, USA – name: 3 Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine, 300 E Superior St #15-703, Chicago, IL 60611, USA – name: 2 Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, 750 N. Lake Shore Drive, 6th Floor, Chicago, IL 60611, USA |
| Author_xml | – sequence: 1 givenname: Ronald T. surname: Ackermann fullname: Ackermann, Ronald T. email: r.ackermann@northwestern.edu organization: Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine – sequence: 2 givenname: Matthew J. surname: O’Brien fullname: O’Brien, Matthew J. organization: Department of Medicine, Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Center for Diabetes and Metabolism, Northwestern University Feinberg School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32080770$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU9v1DAQxS1URP_AB-CCInHhEvA4zto5IbQUqFSJPZSzcZzJrqvEXuxkpX57prtLgUpwsq35vfGbeefsJMSAjL0E_hY4V-8ygG5EyQUvQTRVKZ-wM6irpuRaNCf7uyylFuqUned8ywnkqn7GTivBNVeKn7HvlzvfYXBY2NAVy40dBgxrzEUfU3GTbMiDnXwM-_Iqbufj82rcWjcVsS-mDRYfvW1xItUq4Q7DnliluE52fM6e9nbI-OJ4XrBvny5vll_K66-fr5YfrksnFUyl01r1om0WDlBL6EBK1dR9W-sOVa8U1HXnWnQLKZqWnGsrmk5LTjzUPQ16wd4f-m7ndsTOkYtkB7NNfrTpzkTrzd-V4DdmHXcGgHZZwYI6vDl2SPHHjHkyo88Oh8EGjHM2olrQ2jRIIPT1I_Q2zinQfETVDVSqUoqoV39aevDya_sEwAFwKeacsH9AgJv7hM0hYUPBmfuEjSSNeqRxftpnQlP54b9KcVBm-oUyTr9N_1v0EzfXuaM |
| CitedBy_id | crossref_primary_10_1186_s12875_023_02053_1 crossref_primary_10_1007_s11121_021_01222_x crossref_primary_10_2337_dc21_0677 crossref_primary_10_3390_ijerph191912286 crossref_primary_10_2147_DMSO_S218334 crossref_primary_10_1007_s11892_024_01535_5 crossref_primary_10_1093_tbm_ibac061 crossref_primary_10_3389_fpubh_2023_1277657 crossref_primary_10_1360_TB_2023_0489 crossref_primary_10_1080_19325037_2023_2187487 crossref_primary_10_1016_j_jdiacomp_2022_108220 crossref_primary_10_1186_s12906_022_03755_2 crossref_primary_10_1136_bmjnph_2024_000932 crossref_primary_10_5888_pcd20_230072 crossref_primary_10_2337_dci20_0031 crossref_primary_10_2196_26013 crossref_primary_10_2196_50183 crossref_primary_10_1186_s12913_023_10129_y crossref_primary_10_3389_fdgth_2021_764735 crossref_primary_10_1038_s41598_023_35738_9 crossref_primary_10_1186_s13690_025_01532_4 crossref_primary_10_12688_hrbopenres_13807_1 crossref_primary_10_1016_j_jcjd_2022_01_003 crossref_primary_10_1186_s12875_023_02230_2 crossref_primary_10_2196_52583 crossref_primary_10_2337_dci24_0001 crossref_primary_10_1016_j_ypmed_2022_107089 crossref_primary_10_1136_bmjopen_2024_087274 crossref_primary_10_2337_dc20_3112 crossref_primary_10_2196_50378 crossref_primary_10_1016_j_cct_2021_106427 crossref_primary_10_1146_annurev_publhealth_090419_102644 crossref_primary_10_2196_28884 crossref_primary_10_1186_s13098_022_00848_3 crossref_primary_10_12688_hrbopenres_13807_3 crossref_primary_10_12688_hrbopenres_13807_2 crossref_primary_10_1177_21501319241282862 crossref_primary_10_12688_hrbopenres_13807_4 |
| Cites_doi | 10.1097/QAI.0000000000000230 10.2105/AJPH.2015.302641 10.2337/dc18-2071 10.1056/NEJM200105033441801 10.1016/j.jacc.2009.10.060 10.2337/dc16-2099 10.1038/s41387-018-0036-y 10.1177/0890117118783594 10.1016/j.pmedr.2018.06.009 10.1007/s11606-012-2122-5 10.1001/jamanetworkopen.2019.3160 10.1007/s11606-014-3082-8 10.1016/j.amepre.2012.12.018 10.1016/S2213-8587(16)30321-7 10.1007/s11606-019-05245-7 10.2337/diacare.26.1.36 10.7326/M15-2345 10.1007/s12160-012-9403-4 10.2105/AJPH.93.4.635 10.7326/M14-1796 10.7326/0003-4819-142-5-200503010-00007 10.2337/dc10-1314 10.2337/diacare.28.4.888 10.1097/00005650-200201000-00006 10.1377/hlthaff.2011.1009 10.1186/1471-2458-11-136 10.2105/AJPH.2007.117499 10.1371/journal.pmed.1002074 10.1007/s11606-019-05238-6 10.1177/0145721706297743 10.7326/0003-4819-155-7-201110040-00006 10.1016/j.amepre.2012.12.009 10.1007/s11892-019-1200-z 10.1371/journal.pmed.1002095 10.1177/1740774516669679 10.5888/pcd15.180063 10.1007/s00125-005-0097-z 10.2337/diacare.26.11.3160 10.1016/j.amepre.2018.04.017 10.7326/M15-0469 10.1016/S0140-6736(12)60283-9 10.2337/diacare.20.4.537 10.1007/s11892-012-0256-9 10.2337/ds18-0022 10.1016/j.amepre.2015.03.007 10.2196/jmir.1602 10.1056/NEJMoa012512 10.3122/jabfm.2019.04.180375 10.2337/cd17-0049 10.2337/dc13-2195 10.1093/tbm/ibz098 10.1377/hlthaff.2011.1115 |
| ContentType | Journal Article |
| Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2020 Current Diabetes Reports is a copyright of Springer, (2020). All Rights Reserved. |
| Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2020 – notice: Current Diabetes Reports is a copyright of Springer, (2020). All Rights Reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1007/s11892-020-1293-4 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1539-0829 |
| EndPage | 9 |
| ExternalDocumentID | PMC11100316 32080770 10_1007_s11892_020_1293_4 |
| Genre | Journal Article Review |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: AHRQ HHS grantid: R18 HS026172 |
| GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29F 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 6J9 6NX 6PF 7RV 7X7 875 88E 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD B-. BA0 BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI C1A CAG CCPQU COF CS3 CSCUP CUW DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG6 HMCUK HMJXF HRMNR HZ~ IJ- IKXTQ IWAJR IXC IXD IXE I~Z J-C JBSCW JZLTJ KOV LLZTM M1P M4Y MA- NAPCQ NPVJJ NQJWS NU0 O9- O9J P9S PF0 PQQKQ PROAC PSQYO PT4 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z7W Z82 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c471t-c887f2b96c1e841d144795fb58de7f77155dcbec6429b7708a29d8406c115f153 |
| IEDL.DBID | 7X7 |
| ISSN | 1534-4827 1539-0829 |
| IngestDate | Thu Aug 21 18:35:42 EDT 2025 Fri Sep 05 09:33:40 EDT 2025 Wed Aug 20 03:00:04 EDT 2025 Wed Feb 19 02:05:28 EST 2025 Thu Apr 24 23:02:49 EDT 2025 Tue Jul 01 03:55:10 EDT 2025 Fri Feb 21 02:25:59 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Type 2 diabetes Dissemination of evidence Prediabetes Diabetes prevention Implementation challenges |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c471t-c887f2b96c1e841d144795fb58de7f77155dcbec6429b7708a29d8406c115f153 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11100316 |
| PMID | 32080770 |
| PQID | 2359137377 |
| PQPubID | 2034519 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11100316 proquest_miscellaneous_2362088141 proquest_journals_2359137377 pubmed_primary_32080770 crossref_primary_10_1007_s11892_020_1293_4 crossref_citationtrail_10_1007_s11892_020_1293_4 springer_journals_10_1007_s11892_020_1293_4 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20200300 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 3 year: 2020 text: 20200300 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: United States – name: Philadelphia |
| PublicationTitle | Current diabetes reports |
| PublicationTitleAbbrev | Curr Diab Rep |
| PublicationTitleAlternate | Curr Diab Rep |
| PublicationYear | 2020 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | YancyWSJrShawPAWesbyLHilbertVYangLZhuJFinancial incentive strategies for maintenance of weight loss: results from an internet-based randomized controlled trialNutr Diabetes201881332979536510.1038/s41387-018-0036-y29795365 GenuthSAlbertiKGBennettPBuseJDefronzoRKahnRKitzmillerJKnowlerWCLebovitzHLernmarkANathanDPalmerJRizzaRSaudekCShawJSteffesMSternMTuomilehtoJZimmetPExpert Committee on the Diagnosis and Classification of Diabetes MellitusFollow-up report on the diagnosis of diabetes mellitusDiabetes Care20032611316031671457825510.2337/diacare.26.11.316014578255 AckermannRTLissDTFinchEASchmidtKKHaysLMMarreroDGA randomized comparative effectiveness trial for preventing type 2 diabetesAm J Public Health2015105112328233426378828460517910.2105/AJPH.2015.302641 ZhuoXZhangPGreggEWBarkerLHoergerTJTonyP-CA nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 yearsHealth Aff (Millwood)2012311506010.1377/hlthaff.2011.1115 KnowlerWCBarrett-ConnorEFowlerSEHammanRFLachinJMWalkerEANathanDMDiabetes Prevention Program Research GroupReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med2002346639340310.1056/NEJMoa0125121:CAS:528:DC%2BD38XhtVWqurc%3D MoinTannazDuruO. KenrikTurkNormanChonJanet S.FroschDominick L.MartinJacqueline M.JeffersKia SkrineCastellon-LopezYelbaTsengChi-HongNorrisKeithMangioneCarol M.Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) TrialJournal of General Internal Medicine20193411265226593147172910.1007/s11606-019-05238-631471729 GopalanALorinczISWirtallaCMarcusSCLongJAAwareness of Prediabetes and Engagement in Diabetes Risk-Reducing BehaviorsAm J Prev Med20154945125192609192810.1016/j.amepre.2015.03.00726091928Findings from this study uncover the large prevailing gap in prediabetes awareness in the USA. LaCroixJMSnyderLBHuedo-MedinaTBJohnsonBTEffectiveness of mass media interventions for HIV prevention, 1986-2013: a meta-analysisJ Acquir Immune Defic Syndr201466Suppl 3S329S3402500720410.1097/QAI.000000000000023025007204 VendittiEMKramerMKNecessary components for lifestyle modification interventions to reduce diabetes riskCurr Diab Rep20121221381462235080710.1007/s11892-012-0256-922350807 U.S. Centers for Diseaese Control and Prevention. National Diabetes Prevention Program Atlanta, GA: Centers for Disease Control and Prevention; 2019 [updated August 10, 2019. Available from: https://www.cdc.gov/diabetes/prevention/index.html.] HermanWHBrandleMZhangPWilliamsonDFMatulikMJRatnerRECosts associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention programDiabetes Care2003261364710.2337/diacare.26.1.36 Claxton G, Rae M, Damico A, Young G, McDermott D, Whitmore H, et al. Employer health benefits: 2019 annual survey. San Francisco: The Henry J. Kaiser Family Foundation, (2019). [Available from: https://www.kff.org/health-costs/report/2019-employer-health-benefits-survey/.] AckermannRTKangRCooperAJLissDTHolmesAMMoranMSahaCEffect on health care expenditures during nationwide implementation of the Diabetes Prevention Program as a health insurance benefitDiabetes Care2019429177617833101087010.2337/dc18-207131010870 TuomilehtoJLindstromJErikssonJGValleTTHamalainenHIlanne-ParikkaPPrevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceN Engl J Med20013441813431350113339901133399010.1056/NEJM2001050334418011:STN:280:DC%2BD3M3kvFejsA%3D%3D TabakAGHerderCRathmannWBrunnerEJKivimakiMPrediabetes: a high-risk state for diabetes developmentLancet.201237998332279229022683128389120310.1016/S0140-6736(12)60283-9 ElyEKGrussSMLumanETGreggEWAliMKNhimKA national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention ProgramDiabetes Care201740101331134128500215560631010.2337/dc16-2099 O'BrienMJLeeJYCarnethonMRAckermannRTVargasMCHamiltonAMohantyNRittnerSSParkJNHassanABuchananDRLiuLFeinglassJDetecting dysglycemia using the 2015 United States Preventive Services Task Force screening criteria: a cohort analysis of community health center patientsPLoS Med201613727403739494209710.1371/journal.pmed.1002074 TsengEvaGreerRaquel C.O’RourkePaulYehHsin-ChiehMcGuireMaura M.AlbrightAnn L.MarstellerJill A.ClarkJeanne M.MaruthurNisa M.National Survey of Primary Care Physicians’ Knowledge, Practices, and Perceptions of PrediabetesJournal of General Internal Medicine20193411247524813150209510.1007/s11606-019-05245-731502095 AliMKMcKeever BullardKImperatoreGBenoitSRRolkaDBAlbrightALReach and use of diabetes prevention services in the United States, 2016–2017JAMA Netw Open201925e19316031074808651228510.1001/jamanetworkopen.2019.3160Findings from this study begin to highlight the relative contributions of different barriers to participation in DPP-like programs, including limited healthcare-based detection, risk communication, and referral to DPP-like programs. BurnsRJDonovanASAckermannRTFinchEARothmanAJJefferyRWA theoretically grounded systematic review of material incentives for weight loss: implications for interventionsAnn Behav Med20124433753882290771210.1007/s12160-012-9403-422907712 YarnallKSPollakKIOstbyeTKrauseKMMichenerJLPrimary care: is there enough time for prevention?Am J Public Health200393463564112660210144780310.2105/AJPH.93.4.635 DunkleyAJBodicoatDHGreavesCJRussellCYatesTDaviesMJDiabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysisDiabetes Care20143749229332465272310.2337/dc13-219524652723 HermanWHHoergerTJBrandleMHicksKSorensenSZhangPThe cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose toleranceAnn Intern Med2005142532333215738451270139210.7326/0003-4819-142-5-200503010-00007 AlbrightALGreggEWPreventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention ProgramAm J Prev Med2013444 Suppl 4S346S35123498297453961310.1016/j.amepre.2012.12.009 WarrenBPankowJSMatsushitaKPunjabiNMDayaNRGramsMWoodwardMSelvinEComparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) studyLancet Diabetes Endocrinol20175134422786397910.1016/S2213-8587(16)30321-727863979 LeblancESO'ConnorEWhitlockEPPatnodeCDKapkaTEffectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task ForceAnn Intern Med201115574344472196934210.7326/0003-4819-155-7-201110040-0000621969342 U.S. Centers for Diseaese Control and Prevention. National Diabetes Statistical Report Atlanta, GA, USA: Department of Health and Human Services; Centers for Disease Control and Prevention; 2017 [Available from: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html.] SiuAlbert L.Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine2015163118612650151310.7326/M15-234526501513 MohrDCCuijpersPLehmanKSupportive accountability: a model for providing human support to enhance adherence to eHealth interventionsJ Med Internet Res201113121393123322135310.2196/jmir.1602 (CMS) CfMMS. Medicare Diabetes Prevention Program (MDPP) Expanded Model Baltimore, MD, USA: US Department of Health and Human Services; Centers for Medicare & Medicaid Services, CMS.gov; 2019 [Available from: https://innovation.cms.gov/initiatives/medicare-diabetes-prevention-program/.] PanXRLiGWHuYHWangJXYangWYAnZXHuZXLinJXiaoJZCaoHBLiuPAJiangXGJiangYYWangJPZhengHZhangHBennettPHHowardBVEffects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes StudyDiabetes Care1997204537544909697710.2337/diacare.20.4.5371:STN:280:DyaK2s3ltFaqtw%3D%3D9096977 MudaliarUZabetianAGoodmanMEchouffo-TcheuguiJBAlbrightALGreggEWCardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysisPLoS Med201613727459705496145510.1371/journal.pmed.1002095 KandulaNRMoranMRTangJWO'BrienMJPreventing diabetes in primary care: providers’ perspectives about diagnosing and treating prediabetesClin Diabetes2018361596629382980577500310.2337/cd17-0049 VanEppsEMTroxelABVillamilESaulsgiverKAZhuJChinJYMatsonJAnarellaJRoohanPGestenFVolppKGEffect of process- and outcome-based financial incentives on weight loss among prediabetic New York Medicaid patients: a randomized clinical trialAm J Health Promot20193333723803002145110.1177/089011711878359430021451 SolerREProiaKJacksonMCLanzaAKleinCLeiferJNudging to change: using behavioral economics theory to move people and their health care partners toward effective type 2 diabetes preventionDiabetes Spectr.201831431031930510385624322610.2337/ds18-0022This study proposes a framework for mapping important behavioral biases and principles of behavioral economics to the area of diabetes prevention. FlorezHPanQAckermannRTMarreroDGBarrett-ConnorEDelahantyLKriskaASaudekCDGoldbergRBRubinRRDiabetes Prevention Program Research GroupImpact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trialJ Gen Intern Med201227121594160122692637350929610.1007/s11606-012-2122-5 LiRQuSZhangPChattopadhyaySGreggEWAlbrightAHopkinsDPronkNPEconomic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task ForceAnn Intern Med2015163645246026167962491389010.7326/M15-0469 KeckJWThomasARHieronymusLRoperKLPrediabetes knowledge, attitudes, and practices at an academic family medicine practiceJ Am Board Fam Med20193245055123130057010.3 RT Ackermann (1293_CR28) 2007; 33 1293_CR29 RE Soler (1293_CR61) 2018; 31 1293_CR21 1293_CR1 1293_CR26 EM Venditti (1293_CR17) 2012; 12 J Niederdeppe (1293_CR55) 2008; 98 R Ratner (1293_CR32) 2005; 28 SM Gruss (1293_CR47) 2019; 19 ES Ford (1293_CR6) 2010; 55 B Jayapaul-Philip (1293_CR25) 2018; 15 ES Leblanc (1293_CR18) 2011; 155 X Zhuo (1293_CR34) 2012; 31 PA Shaw (1293_CR58) 2017; 14 RT Ackermann (1293_CR36) 2019; 42 KS Yarnall (1293_CR40) 2003; 93 WH Herman (1293_CR16) 2003; 26 AJ Dunkley (1293_CR22) 2014; 37 H Florez (1293_CR31) 2012; 27 R Li (1293_CR15) 2015; 163 WS Yancy Jr (1293_CR59) 2018; 8 B Warren (1293_CR8) 2017; 5 1293_CR53 1293_CR10 RT Ackermann (1293_CR48) 2015; 105 1293_CR12 NR Kandula (1293_CR45) 2018; 36 HL Walls (1293_CR56) 2011; 11 AL Albright (1293_CR24) 2013; 44 DC Mohr (1293_CR19) 2011; 13 C James (1293_CR14) 2011; 34 JW Keck (1293_CR42) 2019; 32 EM VanEpps (1293_CR60) 2019; 33 RA Bednarczyk (1293_CR52) 2018; 11 A Ramachandran (1293_CR4) 2006; 49 A Gopalan (1293_CR9) 2015; 49 Eva Tseng (1293_CR41) 2019; 34 RL Kravitz (1293_CR51) 2002; 40 RJ Burns (1293_CR57) 2012; 44 WC Knowler (1293_CR2) 2002; 346 XR Pan (1293_CR3) 1997; 20 K Nhim (1293_CR44) 2018; 55 Albert L. Siu (1293_CR38) 2015; 163 MJ O'Brien (1293_CR43) 2016; 13 MK Ali (1293_CR20) 2012; 31 U Mudaliar (1293_CR23) 2016; 13 1293_CR39 Tannaz Moin (1293_CR46) 2019; 34 JM LaCroix (1293_CR54) 2014; 66 D Vojta (1293_CR27) 2013; 44 1293_CR30 AG Tabak (1293_CR7) 2012; 379 1293_CR35 JJ Fenton (1293_CR50) 2015; 30 ML LeFevre (1293_CR37) 2014; 161 MK Ali (1293_CR11) 2019; 2 J Tuomilehto (1293_CR5) 2001; 344 S Genuth (1293_CR13) 2003; 26 WH Herman (1293_CR33) 2005; 142 EK Ely (1293_CR49) 2017; 40 |
| References_xml | – reference: (CMS) CfMMS. Medicare Diabetes Prevention Program (MDPP) Expanded Model Baltimore, MD, USA: US Department of Health and Human Services; Centers for Medicare & Medicaid Services, CMS.gov; 2019 [Available from: https://innovation.cms.gov/initiatives/medicare-diabetes-prevention-program/.] – reference: SiuAlbert L.Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine2015163118612650151310.7326/M15-234526501513 – reference: LaCroixJMSnyderLBHuedo-MedinaTBJohnsonBTEffectiveness of mass media interventions for HIV prevention, 1986-2013: a meta-analysisJ Acquir Immune Defic Syndr201466Suppl 3S329S3402500720410.1097/QAI.000000000000023025007204 – reference: U.S. Centers for Diseaese Control and Prevention. National Diabetes Prevention Program Atlanta, GA: Centers for Disease Control and Prevention; 2019 [updated August 10, 2019. Available from: https://www.cdc.gov/diabetes/prevention/index.html.] – reference: KnowlerWCBarrett-ConnorEFowlerSEHammanRFLachinJMWalkerEANathanDMDiabetes Prevention Program Research GroupReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med2002346639340310.1056/NEJMoa0125121:CAS:528:DC%2BD38XhtVWqurc%3D – reference: YarnallKSPollakKIOstbyeTKrauseKMMichenerJLPrimary care: is there enough time for prevention?Am J Public Health200393463564112660210144780310.2105/AJPH.93.4.635 – reference: AliMKEchouffo-TcheuguiJWilliamsonDFHow effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?Health Aff (Millwood)2012311677510.1377/hlthaff.2011.1009 – reference: AliMKMcKeever BullardKImperatoreGBenoitSRRolkaDBAlbrightALReach and use of diabetes prevention services in the United States, 2016–2017JAMA Netw Open201925e19316031074808651228510.1001/jamanetworkopen.2019.3160Findings from this study begin to highlight the relative contributions of different barriers to participation in DPP-like programs, including limited healthcare-based detection, risk communication, and referral to DPP-like programs. – reference: VojtaDKoehlerTBLongjohnMLeverJACaputoNFA coordinated national model for diabetes prevention: linking health systems to an evidence-based community programAm J Prev Med2013444 Suppl 4S301S3062349829110.1016/j.amepre.2012.12.01823498291 – reference: HermanWHHoergerTJBrandleMHicksKSorensenSZhangPThe cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose toleranceAnn Intern Med2005142532333215738451270139210.7326/0003-4819-142-5-200503010-00007 – reference: RatnerRGoldbergRHaffnerSMarcovinaSOrchardTFowlerSImpact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention programDiabetes Care20052848888941579319110.2337/diacare.28.4.88815793191 – reference: Ariel-Donges AH, Gordon EL, Dixon BN, Eastman AJ, Bauman V, Ross KM, et al. Rural/urban disparities in access to the National Diabetes Prevention Program. Transl Behav Med. 2019 Jun 22. https://doi.org/10.1093/tbm/ibz098. – reference: LeFevreMLForce USPST. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation StatementAnn Intern Med201416185875932515541910.7326/M14-179625155419 – reference: TuomilehtoJLindstromJErikssonJGValleTTHamalainenHIlanne-ParikkaPPrevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceN Engl J Med20013441813431350113339901133399010.1056/NEJM2001050334418011:STN:280:DC%2BD3M3kvFejsA%3D%3D – reference: AlbrightALGreggEWPreventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention ProgramAm J Prev Med2013444 Suppl 4S346S35123498297453961310.1016/j.amepre.2012.12.009 – reference: Patient Protection and Affordable Care Act, (2010). [Available from: http://www.ncsl.org/documents/health/ppaca-consolidated.pdf.] – reference: AckermannRTLissDTFinchEASchmidtKKHaysLMMarreroDGA randomized comparative effectiveness trial for preventing type 2 diabetesAm J Public Health2015105112328233426378828460517910.2105/AJPH.2015.302641 – reference: FordESZhaoGLiCPre-diabetes and the risk for cardiovascular disease: a systematic review of the evidenceJ Am Coll Cardiol20105513131013172033849110.1016/j.jacc.2009.10.06020338491 – reference: JamesCBullardKMRolkaDBGeissLSWilliamsDECowieCCAlbrightAGreggEWImplications of alternative definitions of prediabetes for prevalence in U.S. adultsDiabetes Care201134238739121270196302435410.2337/dc10-1314 – reference: ZhuoXZhangPGreggEWBarkerLHoergerTJTonyP-CA nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 yearsHealth Aff (Millwood)2012311506010.1377/hlthaff.2011.1115 – reference: GopalanALorinczISWirtallaCMarcusSCLongJAAwareness of Prediabetes and Engagement in Diabetes Risk-Reducing BehaviorsAm J Prev Med20154945125192609192810.1016/j.amepre.2015.03.00726091928Findings from this study uncover the large prevailing gap in prediabetes awareness in the USA. – reference: AckermannRTKangRCooperAJLissDTHolmesAMMoranMSahaCEffect on health care expenditures during nationwide implementation of the Diabetes Prevention Program as a health insurance benefitDiabetes Care2019429177617833101087010.2337/dc18-207131010870 – reference: KeckJWThomasARHieronymusLRoperKLPrediabetes knowledge, attitudes, and practices at an academic family medicine practiceJ Am Board Fam Med20193245055123130057010.3122/jabfm.2019.04.18037531300570 – reference: KravitzRLBellRAAzariRKrupatEKelly-ReifSThomDRequest fulfillment in office practice: antecedents and relationship to outcomesMed Care200240138511174842510.1097/00005650-200201000-0000611748425 – reference: LeblancESO'ConnorEWhitlockEPPatnodeCDKapkaTEffectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task ForceAnn Intern Med201115574344472196934210.7326/0003-4819-155-7-201110040-0000621969342 – reference: AckermannRTMarreroDGAdapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA modelDiabetes Educ2007331691727279410.1177/01457217062977431727279474-5, 7-8 – reference: HermanWHBrandleMZhangPWilliamsonDFMatulikMJRatnerRECosts associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention programDiabetes Care2003261364710.2337/diacare.26.1.36 – reference: TsengEvaGreerRaquel C.O’RourkePaulYehHsin-ChiehMcGuireMaura M.AlbrightAnn L.MarstellerJill A.ClarkJeanne M.MaruthurNisa M.National Survey of Primary Care Physicians’ Knowledge, Practices, and Perceptions of PrediabetesJournal of General Internal Medicine20193411247524813150209510.1007/s11606-019-05245-731502095 – reference: MohrDCCuijpersPLehmanKSupportive accountability: a model for providing human support to enhance adherence to eHealth interventionsJ Med Internet Res201113121393123322135310.2196/jmir.1602 – reference: TabakAGHerderCRathmannWBrunnerEJKivimakiMPrediabetes: a high-risk state for diabetes developmentLancet.201237998332279229022683128389120310.1016/S0140-6736(12)60283-9 – reference: GrussSMNhimKGreggEBellMLumanEAlbrightAPublic health approaches to type 2 diabetes prevention: the US National Diabetes Prevention Program and BeyondCurr Diab Rep.20191997831385061668285210.1007/s11892-019-1200-z – reference: YancyWSJrShawPAWesbyLHilbertVYangLZhuJFinancial incentive strategies for maintenance of weight loss: results from an internet-based randomized controlled trialNutr Diabetes201881332979536510.1038/s41387-018-0036-y29795365 – reference: MoinTannazDuruO. KenrikTurkNormanChonJanet S.FroschDominick L.MartinJacqueline M.JeffersKia SkrineCastellon-LopezYelbaTsengChi-HongNorrisKeithMangioneCarol M.Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) TrialJournal of General Internal Medicine20193411265226593147172910.1007/s11606-019-05238-631471729 – reference: AdCouncil. Type 2 Diabetes Prevention New York, NY, USA: The Advertising Council, Inc.; 2019 [Available from: https://www.adcouncil.org/Our-Campaigns/Health/Type-2-Diabetes-Prevention.] – reference: WarrenBPankowJSMatsushitaKPunjabiNMDayaNRGramsMWoodwardMSelvinEComparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) studyLancet Diabetes Endocrinol20175134422786397910.1016/S2213-8587(16)30321-727863979 – reference: NhimKKhanTGrussSMWozniakGKirleyKSchumacherPLumanETAlbrightAPrimary care providers’ prediabetes screening, testing, and referral behaviorsAm J Prev Med2018552e39e4729934016624121310.1016/j.amepre.2018.04.017 – reference: GenuthSAlbertiKGBennettPBuseJDefronzoRKahnRKitzmillerJKnowlerWCLebovitzHLernmarkANathanDPalmerJRizzaRSaudekCShawJSteffesMSternMTuomilehtoJZimmetPExpert Committee on the Diagnosis and Classification of Diabetes MellitusFollow-up report on the diagnosis of diabetes mellitusDiabetes Care20032611316031671457825510.2337/diacare.26.11.316014578255 – reference: Claxton G, Rae M, Damico A, Young G, McDermott D, Whitmore H, et al. Employer health benefits: 2019 annual survey. San Francisco: The Henry J. Kaiser Family Foundation, (2019). [Available from: https://www.kff.org/health-costs/report/2019-employer-health-benefits-survey/.] – reference: FentonJJFranksPFeldmanMDJerantAHenrySGPaternitiDAImpact of patient requests on provider-perceived visit difficulty in primary careJ Gen Intern Med20153022142202537383610.1007/s11606-014-3082-825373836 – reference: SolerREProiaKJacksonMCLanzaAKleinCLeiferJNudging to change: using behavioral economics theory to move people and their health care partners toward effective type 2 diabetes preventionDiabetes Spectr.201831431031930510385624322610.2337/ds18-0022This study proposes a framework for mapping important behavioral biases and principles of behavioral economics to the area of diabetes prevention. – reference: U.S. Centers for Diseaese Control and Prevention. Prediabetes Risk Test Atlanta, GA, USA: U.S. Centers for Disease Control and Prevention; 2019 [Available from: https://www.cdc.gov/prediabetes/takethetest/.] – reference: ElyEKGrussSMLumanETGreggEWAliMKNhimKA national effort to prevent type 2 diabetes: participant-level evaluation of CDC’s National Diabetes Prevention ProgramDiabetes Care201740101331134128500215560631010.2337/dc16-2099 – reference: PanXRLiGWHuYHWangJXYangWYAnZXHuZXLinJXiaoJZCaoHBLiuPAJiangXGJiangYYWangJPZhengHZhangHBennettPHHowardBVEffects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes StudyDiabetes Care1997204537544909697710.2337/diacare.20.4.5371:STN:280:DyaK2s3ltFaqtw%3D%3D9096977 – reference: BurnsRJDonovanASAckermannRTFinchEARothmanAJJefferyRWA theoretically grounded systematic review of material incentives for weight loss: implications for interventionsAnn Behav Med20124433753882290771210.1007/s12160-012-9403-422907712 – reference: BednarczykRAChamberlainAMathewsonKSalmonDAOmerSBPractice-, provider-, and patient-level interventions to improve preventive care: development of the P3 modelPrev Med Rep20181113113830003011604010910.1016/j.pmedr.2018.06.009 – reference: NiederdeppeJFioreMCBakerTBSmithSSSmoking-cessation media campaigns and their effectiveness among socioeconomically advantaged and disadvantaged populationsAm J Public Health200898591692418381998237482910.2105/AJPH.2007.117499 – reference: LiRQuSZhangPChattopadhyaySGreggEWAlbrightAHopkinsDPronkNPEconomic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task ForceAnn Intern Med2015163645246026167962491389010.7326/M15-0469 – reference: DunkleyAJBodicoatDHGreavesCJRussellCYatesTDaviesMJDiabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysisDiabetes Care20143749229332465272310.2337/dc13-219524652723 – reference: VendittiEMKramerMKNecessary components for lifestyle modification interventions to reduce diabetes riskCurr Diab Rep20121221381462235080710.1007/s11892-012-0256-922350807 – reference: U.S. Centers for Diseaese Control and Prevention. Centers for Disease Control and Prevention Diabetes Prevention Recognition Program: Standards and Operating Procedures Atlanta, GA, USA: U.S. Centers for Disease Control and Prevention; 2018 [Available from: https://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf.] – reference: U.S. Centers for Diseaese Control and Prevention. National Diabetes Statistical Report Atlanta, GA, USA: Department of Health and Human Services; Centers for Disease Control and Prevention; 2017 [Available from: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html.] – reference: RamachandranASnehalathaCMarySMukeshBBhaskarADVijayVIndian Diabetes Prevention Programme (IDPP)The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia.20064922892971639190310.1007/s00125-005-0097-z1:CAS:528:DC%2BD28XhtFWnurc%3D16391903 – reference: O'BrienMJLeeJYCarnethonMRAckermannRTVargasMCHamiltonAMohantyNRittnerSSParkJNHassanABuchananDRLiuLFeinglassJDetecting dysglycemia using the 2015 United States Preventive Services Task Force screening criteria: a cohort analysis of community health center patientsPLoS Med201613727403739494209710.1371/journal.pmed.1002074 – reference: WallsHLPeetersAProiettoJMcNeilJJPublic health campaigns and obesity - a critiqueBMC Public Health20111113621352562305674710.1186/1471-2458-11-136 – reference: Jayapaul-PhilipBDaiSKirtlandKHaslamANhimKAvailability of the National Diabetes Prevention Program in United States Counties, March 2017Prev Chronic Dis20181530191810613028310.5888/pcd15.180063 – reference: MudaliarUZabetianAGoodmanMEchouffo-TcheuguiJBAlbrightALGreggEWCardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysisPLoS Med201613727459705496145510.1371/journal.pmed.1002095 – reference: VanEppsEMTroxelABVillamilESaulsgiverKAZhuJChinJYMatsonJAnarellaJRoohanPGestenFVolppKGEffect of process- and outcome-based financial incentives on weight loss among prediabetic New York Medicaid patients: a randomized clinical trialAm J Health Promot20193333723803002145110.1177/089011711878359430021451 – reference: Tice JA, Chapman R, Shore KK, Seidner M, Ollendorf DA, Weissberg J, et al. Diabetes prevention programs: effectiveness and value. Boston: Institute for Clinical and Economic Review, (2016). [Available from: https://icer-review.org/wpcontent/uploads/2016/05/CTAF_DPP_Draft_Evidence_Report_050916-1.pdf.] – reference: ShawPAYancyWSJrWesbyLUlrichVTroxelABHuffmanDThe design and conduct of Keep It Off: An online randomized trial of financial incentives for weight-loss maintenanceClin Trials201714129362764650810.1177/174077451666967927646508 – reference: FlorezHPanQAckermannRTMarreroDGBarrett-ConnorEDelahantyLKriskaASaudekCDGoldbergRBRubinRRDiabetes Prevention Program Research GroupImpact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trialJ Gen Intern Med201227121594160122692637350929610.1007/s11606-012-2122-5 – reference: KandulaNRMoranMRTangJWO'BrienMJPreventing diabetes in primary care: providers’ perspectives about diagnosing and treating prediabetesClin Diabetes2018361596629382980577500310.2337/cd17-0049 – volume: 66 start-page: S329 issue: Suppl 3 year: 2014 ident: 1293_CR54 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0000000000000230 – volume: 105 start-page: 2328 issue: 11 year: 2015 ident: 1293_CR48 publication-title: Am J Public Health doi: 10.2105/AJPH.2015.302641 – volume: 42 start-page: 1776 issue: 9 year: 2019 ident: 1293_CR36 publication-title: Diabetes Care doi: 10.2337/dc18-2071 – volume: 344 start-page: 1343 issue: 18 year: 2001 ident: 1293_CR5 publication-title: N Engl J Med doi: 10.1056/NEJM200105033441801 – volume: 55 start-page: 1310 issue: 13 year: 2010 ident: 1293_CR6 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2009.10.060 – volume: 40 start-page: 1331 issue: 10 year: 2017 ident: 1293_CR49 publication-title: Diabetes Care doi: 10.2337/dc16-2099 – volume: 8 start-page: 33 issue: 1 year: 2018 ident: 1293_CR59 publication-title: Nutr Diabetes doi: 10.1038/s41387-018-0036-y – volume: 33 start-page: 372 issue: 3 year: 2019 ident: 1293_CR60 publication-title: Am J Health Promot doi: 10.1177/0890117118783594 – volume: 11 start-page: 131 year: 2018 ident: 1293_CR52 publication-title: Prev Med Rep doi: 10.1016/j.pmedr.2018.06.009 – ident: 1293_CR10 – volume: 27 start-page: 1594 issue: 12 year: 2012 ident: 1293_CR31 publication-title: J Gen Intern Med doi: 10.1007/s11606-012-2122-5 – volume: 2 start-page: e193160 issue: 5 year: 2019 ident: 1293_CR11 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2019.3160 – volume: 30 start-page: 214 issue: 2 year: 2015 ident: 1293_CR50 publication-title: J Gen Intern Med doi: 10.1007/s11606-014-3082-8 – volume: 44 start-page: S301 issue: 4 Suppl 4 year: 2013 ident: 1293_CR27 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2012.12.018 – volume: 5 start-page: 34 issue: 1 year: 2017 ident: 1293_CR8 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30321-7 – volume: 34 start-page: 2475 issue: 11 year: 2019 ident: 1293_CR41 publication-title: Journal of General Internal Medicine doi: 10.1007/s11606-019-05245-7 – volume: 26 start-page: 36 issue: 1 year: 2003 ident: 1293_CR16 publication-title: Diabetes Care doi: 10.2337/diacare.26.1.36 – volume: 163 start-page: 861 issue: 11 year: 2015 ident: 1293_CR38 publication-title: Annals of Internal Medicine doi: 10.7326/M15-2345 – ident: 1293_CR39 – ident: 1293_CR53 – volume: 44 start-page: 375 issue: 3 year: 2012 ident: 1293_CR57 publication-title: Ann Behav Med doi: 10.1007/s12160-012-9403-4 – volume: 93 start-page: 635 issue: 4 year: 2003 ident: 1293_CR40 publication-title: Am J Public Health doi: 10.2105/AJPH.93.4.635 – volume: 161 start-page: 587 issue: 8 year: 2014 ident: 1293_CR37 publication-title: Ann Intern Med doi: 10.7326/M14-1796 – volume: 142 start-page: 323 issue: 5 year: 2005 ident: 1293_CR33 publication-title: Ann Intern Med doi: 10.7326/0003-4819-142-5-200503010-00007 – volume: 34 start-page: 387 issue: 2 year: 2011 ident: 1293_CR14 publication-title: Diabetes Care doi: 10.2337/dc10-1314 – volume: 28 start-page: 888 issue: 4 year: 2005 ident: 1293_CR32 publication-title: Diabetes Care doi: 10.2337/diacare.28.4.888 – volume: 40 start-page: 38 issue: 1 year: 2002 ident: 1293_CR51 publication-title: Med Care doi: 10.1097/00005650-200201000-00006 – volume: 31 start-page: 67 issue: 1 year: 2012 ident: 1293_CR20 publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2011.1009 – volume: 11 start-page: 136 year: 2011 ident: 1293_CR56 publication-title: BMC Public Health doi: 10.1186/1471-2458-11-136 – volume: 98 start-page: 916 issue: 5 year: 2008 ident: 1293_CR55 publication-title: Am J Public Health doi: 10.2105/AJPH.2007.117499 – ident: 1293_CR29 – ident: 1293_CR21 – volume: 13 issue: 7 year: 2016 ident: 1293_CR43 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002074 – volume: 34 start-page: 2652 issue: 11 year: 2019 ident: 1293_CR46 publication-title: Journal of General Internal Medicine doi: 10.1007/s11606-019-05238-6 – volume: 33 start-page: 69 issue: 1 year: 2007 ident: 1293_CR28 publication-title: Diabetes Educ doi: 10.1177/0145721706297743 – volume: 155 start-page: 434 issue: 7 year: 2011 ident: 1293_CR18 publication-title: Ann Intern Med doi: 10.7326/0003-4819-155-7-201110040-00006 – volume: 44 start-page: S346 issue: 4 Suppl 4 year: 2013 ident: 1293_CR24 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2012.12.009 – ident: 1293_CR35 – volume: 19 start-page: 78 issue: 9 year: 2019 ident: 1293_CR47 publication-title: Curr Diab Rep. doi: 10.1007/s11892-019-1200-z – ident: 1293_CR12 – volume: 13 issue: 7 year: 2016 ident: 1293_CR23 publication-title: PLoS Med doi: 10.1371/journal.pmed.1002095 – volume: 14 start-page: 29 issue: 1 year: 2017 ident: 1293_CR58 publication-title: Clin Trials doi: 10.1177/1740774516669679 – volume: 15 year: 2018 ident: 1293_CR25 publication-title: Prev Chronic Dis doi: 10.5888/pcd15.180063 – volume: 49 start-page: 289 issue: 2 year: 2006 ident: 1293_CR4 publication-title: Diabetologia. doi: 10.1007/s00125-005-0097-z – volume: 26 start-page: 3160 issue: 11 year: 2003 ident: 1293_CR13 publication-title: Diabetes Care doi: 10.2337/diacare.26.11.3160 – volume: 55 start-page: e39 issue: 2 year: 2018 ident: 1293_CR44 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2018.04.017 – volume: 163 start-page: 452 issue: 6 year: 2015 ident: 1293_CR15 publication-title: Ann Intern Med doi: 10.7326/M15-0469 – volume: 379 start-page: 2279 issue: 9833 year: 2012 ident: 1293_CR7 publication-title: Lancet. doi: 10.1016/S0140-6736(12)60283-9 – volume: 20 start-page: 537 issue: 4 year: 1997 ident: 1293_CR3 publication-title: Diabetes Care doi: 10.2337/diacare.20.4.537 – volume: 12 start-page: 138 issue: 2 year: 2012 ident: 1293_CR17 publication-title: Curr Diab Rep doi: 10.1007/s11892-012-0256-9 – volume: 31 start-page: 310 issue: 4 year: 2018 ident: 1293_CR61 publication-title: Diabetes Spectr. doi: 10.2337/ds18-0022 – ident: 1293_CR1 – volume: 49 start-page: 512 issue: 4 year: 2015 ident: 1293_CR9 publication-title: Am J Prev Med doi: 10.1016/j.amepre.2015.03.007 – volume: 13 issue: 1 year: 2011 ident: 1293_CR19 publication-title: J Med Internet Res doi: 10.2196/jmir.1602 – volume: 346 start-page: 393 issue: 6 year: 2002 ident: 1293_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa012512 – ident: 1293_CR30 – volume: 32 start-page: 505 issue: 4 year: 2019 ident: 1293_CR42 publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2019.04.180375 – volume: 36 start-page: 59 issue: 1 year: 2018 ident: 1293_CR45 publication-title: Clin Diabetes doi: 10.2337/cd17-0049 – volume: 37 start-page: 922 issue: 4 year: 2014 ident: 1293_CR22 publication-title: Diabetes Care doi: 10.2337/dc13-2195 – ident: 1293_CR26 doi: 10.1093/tbm/ibz098 – volume: 31 start-page: 50 issue: 1 year: 2012 ident: 1293_CR34 publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2011.1115 |
| SSID | ssj0020075 |
| Score | 2.420958 |
| SecondaryResourceType | review_article |
| Snippet | Purpose of Review
Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that... Type 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that resource-intensive... Purpose of ReviewType 2 diabetes is common, burdensome, and preventable. Landmark trials such as the Diabetes Prevention Program (DPP) demonstrated that... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 9 |
| SubjectTerms | Adult Diabetes Diabetes Mellitus, Type 2 - prevention & control Economics and Policy in Diabetes (AA Baig and N Laiteerapong Exercise Health Promotion Humans Life Style Medicine Medicine & Public Health Prediabetic State - prevention & control Prevention programs Program Evaluation Public Health Section Editors Topical Collection on Economics and Policy in Diabetes United States Weight Loss |
| SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT8MwDLZgSIgL70dhoCBxAnVq2qZZjtM0ngJxYNI4laZJBQJ1iG0Xfj1O23QaL2nnuI8kdmzLXz4DnHgB-hBFIxeD48DFfCN00ctpV0omjUvBCLVA-d5Fl_3wesAG1T3ukUW725JkcVJPL7vRtkFK-gZNIPC9i7DEMD9Ba1zqXDze9Oo8yyv5ddGWQ9ewXNpi5m8vmXVHP2LMn1DJb_XSwg2dr8GDnUCJPnltTcaylX5-43acc4brsFqFpaRT6tEGLOh8E5Zvq8L7FjzZ7qMkyRXp2g4sI4IxLyn8XYmpK4bv66Zg5Kq4hEmGGcFAk1TwmxGxxFEocV8CxLahf9576F66VXMGN0V_NnZTPJ0yX4oopRo3QWFixgXLJGsrzTPOMU5RKSoI5jdCcu61E18ozCZRnrIM92YHGvkw13tAJAaFWjM_SqUXqiBJeChSoVTGkiRhInLAs3sUpxVzuWmg8RZPOZfNysW4crFZuTh04LR-5L2k7fhPuGk3Pq4seBT7ARM04AHnDhzXw2h7pqCS5Ho4MTKRj6c0DakDu6We1F8LcMTDeTvQntGgWsDwes-O5C_PBb83NTR-AcV5n1k9mf7Xn7PYn0v6AFZ8o2gFmq4JjfHHRB9ieDWWR5U5fQE3ARmc priority: 102 providerName: Springer Nature |
| Title | Evidence and Challenges for Translation and Population Impact of the Diabetes Prevention Program |
| URI | https://link.springer.com/article/10.1007/s11892-020-1293-4 https://www.ncbi.nlm.nih.gov/pubmed/32080770 https://www.proquest.com/docview/2359137377 https://www.proquest.com/docview/2362088141 https://pubmed.ncbi.nlm.nih.gov/PMC11100316 |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1RT9swED4NKk28oLExCANkpD0NWYuTOI6fpoJauqFVFaJS9xTi2BFIKAVa_v_OjpOqIHiKVF-V-M72fZf7cgfwPYzRh2iWUgTHMcV4I6Ho5QxViivrUhChOpbvOB1Nkz8zPvMv3BaeVtmeie6g1vPSviP_GcVcsljEQvx6eKS2a5TNrvoWGhvQY4hEbOsGMVsFXGFTaBc3dUJtucs2q-k-nWOZ5V1Glpsg8SnX_dIrsPmaM_kicer80fATbHsgSfqN5Xfgg6k_w8e_PlX-BW7afqGkqDU5b3umLAiiVOI8VMOCc8OTro0X-e0-myTziiA0JJ4wsyBtqSeUmDSUrl2YDgfX5yPq2ynQEj3QkpZ4nlSRkmnJTJYwjaGUkLxSPNNGVEIgstAlmhQjEqmECLMikhrjP5RnvEIlfoXNel6bfSAKYZwxPEpLFSY6LgqRyFJqXfGiKLhMAwhbZealrzVuW17c56sqyVb_Oeo_t_rPkwB-dH95aAptvCd82Foo93tuka9WSAAn3TDuFpsCKWozf7YyaYTnKktYAHuNQbu7xTgS4rwDyNZM3QnYStzrI_XdravIzWzhvZjhvE_bVbF6rjdncfD-LL7BVmTXpyO8HcLm8unZHCECWqpjt8yPode_-Hc5wOvZYDy5wl-nUf8_83YEbw |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9QwDLemmwS8IL7pGBAkeAFVNG3TNA8TgrHpjm2nE9qkvXVNkwqkqTe4mxD_HH8bdpr0dEzsbc9xP-w4sR07PwO8TjK0IYYXMTrHWYzxRh6jlbOx1kKTSUEP1VX5TovxSf7lVJxuwJ9wF4bKKsOe6DZqM2_ojPx9mgnFM5lJ-eHiR0xdoyi7Glpo1L61gtlxEGP-YseB_f0LQ7jFzuQzzvebNN3fO94dx77LQNzgxryMG1xmbapV0XBb5txghCGVaLUojZWtlPhC0yCn6KgrLWVS1qkyGBYhPRctp64RaAI2czpAGcHmp73p7OsQ8iU91C9S5TEBboa8qru8x0uq_EypOkKhnNYt4xV392rV5j-pW2cR9-_BXe_Kso-97t2HDds9gFtHPln_EM5Cx1JWd4bthq4tC4Z-MnM2sq_Dc8OzoZEYm7iLm2zeMnROmS_ZWbAANoUUs76o7BGc3IioH8Oom3f2KTCNjqS1Ii0aneQmq2uZq0YZ04q6roUqIkiCMKvGo51T043zaoXTTPKvUP4Vyb_KI3g7PHLRQ31cR7wdZqjyq35RrXQ0glfDMK5XSsLUnZ1fEk2R4s7Ocx7Bk35Ch69lOJIg3xGUa1M9EBAW-PpI9_2bwwTnBP2XceT7XdCK1X_9l4ut67l4CbfHx0eH1eFkevAM7qSkq678bhtGy5-X9jn6Y0v9wis9g7ObXmd_Ae5aQro |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VrVRxQVBegVKMBBeQ1diJ4_hQob5WXQqrFaJSb2kcOyoSyhZ2K8Rf5FcxduysloreevZkNzMezyMz_gbgTZqhDzGsoBgcZxTzjZyil7NUa6GdS8EI1Xf5ToqTs_zjuThfgz_xLoxrq4w20RtqM2vcN_JdngnFMplJuduGtojp0ejD1Q_qJki5Smscp1GHMQtmz8ONhUsep_b3L0zn5nvjI9z7t5yPjr8entAwcYA2aKQXtMEj13KtiobZMmcGsw2pRKtFaaxspcQfNA1yjUG70lKmZc2VwRQJ6ZlomZsgge5gQ6LXx0Rw4-B4Mv0ypH9pD_uLVDl14Juxxuov8rHSdYFy1ymhUGarXvJG6Huzg_OfMq73jqMHcD-EtWS_18OHsGa7Ldj8HAr3j-AiTi8ldWfIYZzgMicYMxPvL_uePL88HYaKkbG_xElmLcFAlYT2nTmJwFNIMe0bzB7D2Z2I-gmsd7POPgOiMai0VvCi0WlusrqWuWqUMa2o61qoIoE0CrNqAvK5G8DxvVpiNjv5Vyj_ysm_yhN4Nzxy1cN-3Ea8HXeoChZgXi31NYHXwzKeXVeQqTs7u3Y0BUcrz3KWwNN-Q4d_y3AlRb4TKFe2eiBwuOCrK923S48PzhwMYMaQ7_dRK5bv9V8unt_OxSvYxPNWfRpPTl_APe5U1XfibcP64ue1fYmh2ULvBJ0ncHHXx-wvVSBG_g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+and+Challenges+for+Translation+and+Population+Impact+of+the+Diabetes+Prevention+Program&rft.jtitle=Current+diabetes+reports&rft.au=Ackermann%2C+Ronald+T&rft.au=O%27Brien%2C+Matthew+J&rft.date=2020-03-01&rft.eissn=1539-0829&rft.volume=20&rft.issue=3&rft.spage=9&rft_id=info:doi/10.1007%2Fs11892-020-1293-4&rft_id=info%3Apmid%2F32080770&rft.externalDocID=32080770 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1534-4827&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1534-4827&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1534-4827&client=summon |